\n
<\/p>\n
Nearly 90,000 bottles of children\u2019s ibuprofen have been recalled across the United States, according to an enforcement report this week from the Food and Drug Administration (FDA). <\/p>\n<\/div>\n
Strides Pharma Inc. has recalled 89,952 bottles of Children\u2019s Ibuprofen Oral Suspension following customer complaints of a \u201cgel-like mass and black particles\u201d in the medicine.<\/p>\n
The India-based company had manufactured the ibuprofen for Taro Pharmaceuticals U.S.A., Inc. based in Hawthorne, New York. The recall comes from Strides Pharma\u2019s Bridgewater, New Jersey, subsidiary.\u00a0<\/p>\n
Strides Pharma initiated the recall on March 2, with the FDA labeling it a Class II recall<\/a> on Monday, March 16. <\/p>\n<\/div>\n A Class II indicates a situation in which use or exposure to the product could cause \u201ctemporary or medically reversible adverse health consequences\u201d with a very small possibility of serious adverse health consequences.\u00a0<\/p>\n Wondering if your medicine is impacted? Here\u2019s all the information we have on the ibuprofen recall.<\/p>\n The impacted medication is Children\u2019s Ibuprofen Oral Suspension, USP, 100 mg per 5mL, in 4 FL OZ (120 mL) bottles. Two lots are included in the recall:<\/p>\n<\/div>\nWhat products are affected?<\/h2>\n